CHU - Hospital de la Timone

Marseille 13385

0 studies enrolling now · 3 studies all time

What they study most

CMS, Congenital Myasthenic Syndrome, Multiple System Atrophy

Studies at this site

• A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS) — Running, not enrolling
• A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) — Running, not enrolling
• Study of BHV-3241 in Participants With Multiple System Atrophy — Completed